Journal of Chemistry

Journal of Chemistry / 2020 / Article

Review Article | Open Access

Volume 2020 |Article ID 5097542 |

Meiting Wu, Lin Ni, Haixiao Lu, Huiyou Xu, Shuangquan Zou, Xiaoxing Zou, "Terpenoids and Their Biological Activities from Cinnamomum: A Review", Journal of Chemistry, vol. 2020, Article ID 5097542, 14 pages, 2020.

Terpenoids and Their Biological Activities from Cinnamomum: A Review

Academic Editor: Ponnurengam Malliappan Sivakumar
Received28 Apr 2020
Revised04 Jun 2020
Accepted15 Jun 2020
Published14 Jul 2020


Cinnamomum is a genus of the family Lauraceae, which has been recognized worldwide as an important genus due to its beneficial uses. A great deal of research on its phytochemistry and pharmacological effects has been conducted. It is noteworthy that terpenoids are the characteristic of Cinnamomum due to the peculiar structures and significant biological effects. For a more in-depth study and the better use of Cinnamomum plants in the future, the chemical structures and biological effects of terpenoids obtained from Cinnamomum were summarized in the present study. To date, a total of 181 terpenoids with various skeletons have been isolated from Cinnamomum. These compounds have been demonstrated to play an important role in immunomodulatory, anti-inflammatory, antimicrobial, antioxidant, and anticancer activities. However, studies on the bioactive components from Cinnamomum plants have only focused on a dozen species. Hence, further studies on the potential pharmacological effects need to be conducted in the future.

1. Introduction

Cinnamomum, which is a genus of the family Lauraceae, is represented by evergreen trees and shrubs [1]. Approximately 250 species of this genus have been found around the world and are mainly distributed in tropical and subtropical regions of Southeast Asia, Australia, and North, Central, and South America. There are approximately 46 species in China, and these are mainly in the southern religions. Yunnan province has the most species, followed by Guangdong and Sichuan [2, 3].

Cinnamomum has been recognized worldwide as an important genus due to its beneficial uses. This has been traditionally used in flavoring food and in folk medicine for its sweating, antipyretic, and analgesic effects [4]. Some Cinnamomum species, including C. cassia, C. zeylanicum, C. tamala, and C. wilsonii, are famous herbs that have a long history of being used as medicine. In addition, the extracted essential oil from C. camphora, with the main ingredients of eucalyptol, linalool, and camphor, is an important raw material for the chemical industry and medicine. Furthermore, the Cinnamomi cortex, which is obtained from some Cinnamomum species, has been used for treating cardiovascular, chronic gastrointestinal, and inflammatory diseases [5, 6]. Cinnamaldehyde, which is the main constituent of the volatile oil of C. cassia bark, has been mainly used in medicine, foods, and cosmetics and has been proven to exert antifungal and antibacterial activities [7].

To date, many studies on phytochemistry of the genus Cinnamomum have been conducted. Over 500 compounds have been obtained from Cinnamomum plants, which cover lignans, terpenoids, flavonoids, phenylpropanoids, alkaloids, steroids, and butanolides. Among these compounds, approximately 300 compounds are from C. Cassia, which is the most thoroughly studied. This has been reported to show many special contents, particularly terpenoids. Other species also contain a number of unique terpenoids with rare structures, which can only be found from certain species. More importantly, terpenoids, which are the most abundant and diverse compounds in this genus, have also been proven to show great pharmacological activities, including immunomodulatory, anti-inflammatory, antimicrobial, antioxidant, and anticancer activities. Thus, the present review aimed at summarizing the phytochemistry and pharmacological effects of terpenoids from Cinnamomum species and providing a basis for the future in-depth study of the genus Cinnamomum.

2. Chemical Constituents and Biological Activities

A number of studies on the phytochemistry of the genus Cinnamomum have been conducted, and focus has been given on approximately 14 species. From these studies, the genus has been shown to possess abundant and various terpenoids with unique structures. To date, a total of 181 terpenoids have been isolated from the genus Cinnamomum, including 43 monoterpenes, 83 sesquiterpenes, 53 diterpenes, and two triterpenes. Among these compounds, 119 terpenoids were obtained from C. cassia, 21 terpenoids were obtained from C. wilsonii, 19 terpenoids were obtained from C. camphora, 18 terpenoids were obtained from C. glanduliferum, 17 terpenoids were obtained from C. subavenium, eight terpenoids were obtained from C. zeylanicum, eight terpenoids were obtained from C. osmophloeum, three terpenoids were obtained from C. inunctum, three terpenoids were obtained from C. philippinense, two terpenoids were obtained from C. kotoense, one terpenoid was obtained from C. burmannii, one terpenoid was obtained from C. parthenoxylon, one terpenoid was obtained from C. reticulatum, and one terpenoid was obtained from C. tenuifolium, respectively.

2.1. Monoterpenes

A total of 43 monoterpenes have been reported from Cinnamomum (Table 1 and Figure 1), including 24 cyclic monoterpenes (117, 3743) and 19 acyclic monoterpenes (1836). Among these cyclic monoterpenes, compounds 113 are menthane monoterpenes, which are the most abundant types in the genus Cinnamomum. In addition, compounds 612 are the common constituents in the volatile oils of Cinnamomum plants. Compounds 14 and 15 are camphane monoterpenes and camphor (15), along with linalool (29) and eucalyptol (41), is one of the main components of volatile oil in C. camphora. Compounds 16 and 17 belong to the pinane-type monoterpenes, which are common in volatile oils. Monoterpenes 1836 are laurane-type monoterpenes. Among these, compounds 1824 have a geranylphenylacetate skeleton connected to glucose. Compounds 1821, 23, and 24 were further cyclized to form a tetrahydrofuran ring. Interestingly, these compounds were only isolated from C. cassia and are the characteristic compounds for this species. Extracted from C. inunctum, compounds 2527 were monoterpene lactones. Based on this structure, the original hydroxyl groups at the C-4 and C-7 positions of compound 27 were further cyclized to form a rare spironolactone structure. Obtained from C. camphora, compound 33 is an acyclic monoterpene with one carbon degraded and has shown strong anti-inflammatory activity. Compounds 37 and 38 are normonoterpenes from C. reticulatum, with one carbon degraded. Subamone (43), which was obtained from C. subavenium, has a cycloheptanone skeleton and has strong antitumor activity.

No.TypeCompoundMolecular formulaMolecular weightOriginReferences

1Menthane(3R,4R)-p-Menth-1-ene-3,4-diol 3-O-β-D-glucopyranosideC16H28O7332s[8]
2(3R,4S,6R)-p-Menth-1-ene-3,6-diol 3-O-β-D -glucopyranosideC16H28O7332s[8]
6α-TerpineolC10H18O154c, d, g, o[1012]
7α-PhellandreneC10H16136d, g[10, 13]
8α-TerpineneC10H16136d, g[10, 13]
10TerpinoleneC10H16136d, g[10, 13]
12LimoneneC10H16136g, z[10, 11]
13(1R,2R,4S,6S)-4-(2-Hydroxypropan-2-yl)-1-methyl-7-oxabicy clo[4.1.0]heptan-2-olC10H18O3186c[14]

14CamphaneBorneolC10H18O154c, g, z, o[1012]
15CamphorC10H16O152c, d, g[10, 13]

16Pinaneα-PineneC10H16136d, g, z[10, 11]
17β-PineneC10H16136c, d, g[10, 11]

18LauraneCinnacasside AC25H36O11512c[1517]
19Cinnacasside BC25H36O11512c[1517]
20Cinnacasside CC25H36O11512c[1517]
21Cinnacasside DC25H36O11512c[15]
22Cinnacasside EC25H38O11514c[15]
23Cinnacasside FC26H40O12544c[17]
24Cinnacasside GC26H40O12545c[17]
29LinaloolC10H18O154c, d[19, 20]
36Geranyl acetateC12H20O2196c[20]

38(3,3-Dimethylcyclohex-1-ene-1,4-diyl) dimethanolC15H26O7318c[14]

39Othersα-ThujeneC10H16136d, g[10]
40SabineneC10H16136d, g[10]
41EucalyptolC10H18O154d, g[10, 13]
42CampheneC10H16136c, d, g[13, 20]
43SubamoneC10H16O2168s[23, 24]

Note: b: C. burmannii; c: C. cassia; d: C. camphora; g: C. glanduliferum; i: C. inunctum; k: C. kotoense; o: C. osmophloeum; p: C. parthenoxylon; q: C. philippinense; r: C. reticulatum; s: C. subavenium; t: C. tenuifolium; w: C. wilsonii; z: C. zeylanicum. The same is given in Figure 1.

Some monoterpenes from Cinnamomum plants have shown potent antimicrobial activities. Carvacrol (4) showed a broad spectrum of antibacterial activity against both Gram-positive and Gram-negative bacteria [25]. The antimicrobial activity of compound 4 against numerous bacteria was studied and it showed a high inhibitory effect against all these strains, including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumonia, Escherichia coli, Klebsiella pneumonia, Enterobacter spp., Serratia spp., and Proteus mirabilis [26]. Furthermore, 4 is also effective against various fungi, such as Aspergillus niger, Aspergillus flavus, Alternaria alternata, Penicillium rubrum, Trichoderma viride, Candida spp., and dermatophytes [27]. The antibacterial activity of compounds 4 and 9 (a precursor of 4) was studied against the foodborne microorganism V. cholerae. Compound 4 exerted a good inhibitory effect against V. cholerae, while 9 exhibited a weak activity. However, it was interesting to find that the inhibitory effects were enhanced when the two compounds were used together, showing a synergistic effect [28]. According to the findings both 16 and 29 exerted antibacterial activity against E. faecalis and S. aureus, and 16 showed antifungal activity against C. albicans. Similarly, compound 7 was effective against Ae. aegypti and Ae. albopictus [29], as well as Culex pipiens molestus [30].

The antioxidant activities of some monoterpenes were evaluated. The assessment on antioxidant capacity of carvacrol (4) showed that 4 at the doses of 25 (49.79 IU/mg) and 50 mg/kg (52.43 IU/mg) enhanced the level of hippocampal SOD activity in ischemic rats, when compared with the ischemic group (42.9 IU/mg). In the DPPH assay, the percentage of oxidant inhibition was significantly increased in the ischemic group treated with 4 at doses of 25 (41.5%) and 50 mg/kg (36.83%), when compared to the untreated ischemic group (11.29%) [31]. Hakimi et al. confirmed that three doses of compound 4 (25, 50, and 100 mg/kg) could significantly increase the thiol content and improve the activities of both CAT and SOD compared with LPS groups in the hippocampus of rats [32]. In the trolox equivalent antioxidant capacity assay, the antioxidant effects of compounds 4 and 5 were evaluated and compared to that of the synthetic antioxidant trolox. Both compounds have exerted significant antioxidant activity similar to trolox, and the capacity of 4 has been proven to be higher than that of its isomer thymol at the same concentration [25]. Moreover, the antioxidant potential of p-cymene (9) was evaluated in the hippocampus of adult mice. The treatment with 9 at a concentration of 50 mg/kg (0.42 ± 0.03) has produced a significant decrease in lipid peroxidation 65.54%, when compared with the control group. Furthermore, compound 9 at all tested doses (50, 100, and 150 mg/kg) could significantly decrease the nitrite content and produce an increase in SOD and catalase activities [33].

Some monoterpenes were reported to show significant anti-inflammatory effects. Cyclooxygenase-2 (COX-2) is a rate-limiting enzyme in prostaglandin biosynthesis, which plays a key role in inflammation. In human macrophage-like U937 cells, compound 4 was shown to suppress the LPS-induced expression of COX-2 and activate the peroxisome proliferator-activated receptors (PPAR) α and γ [34]. Furthermore, 4 could also inhibit the production and actions of NO [25]. Moreover, NF-κB has been reported to play an important role in the inflammatory response and LPS/GalN-induced liver injury [35]. The effects of linalool (29) on NF-κB expression were assessed, and it was found that 29 could significantly inhibit LPS-induced p65 NF-κB translocation into the nucleus and IκBα degradation. In addition to the NF-κB inhibition, compound 29 could also induce antioxidant defense via Nrf2 activating and consequently protect against LPS/GalN-induced liver injury [36]. Other than this, another study demonstrated that 29 protected against CS-induced lung inflammation through inhibiting CS-induced NF-κB activation [37].

The anticancer activity of linalool (29) against human prostate cancer (DU145) cells was evaluated by the MTT assay and it was observed that 4.36%, 11.54%, 21.88%, and 15.54% of the cells underwent early apoptosis after treatment with 0, 20, 40, and 80 μM of 29, respectively [38]. In addition, Okumura et al. confirmed that terpinolene (10) could markedly reduce the expression of protein kinase AKT, which can mediate cell proliferation and survival signals, and contribute to cancer progression [39].

In an immunosuppression assay, Zeng et al. found that monoterpenes 18, 19, and 23 exhibited potent immunosuppressive activities against murine lymphocytes. Compound 23 inhibited the proliferation of T cells and B cells with an inhibitory ratio of 36.1% and 20.3%, respectively, at a concentration of 400 μM [17]. In another assay, the effect of α-terpineol (6) on the generation of nitric oxide in macrophages induced by LPS was evaluated. The nitrite production induced by LPS in these cells was reduced at all concentrations of compound 4 tested (1, 10, and 100 μg/mL) [40]. Rufino et al. reported that α-pinene (16) could decrease NO production in a dose-dependent manner in primary human chondrocytes, showing the highest inhibition of NO production at a dose of 200 μg/mL, with a decrease to 31.5% relative to cells treated with IL-1β alone [41].

2.2. Sesquiterpenes

A total of 83 sesquiterpenoids (44126) were isolated from Cinnamomum plants, which contain multiple structural types (Table 2 and Figure 2).

No.TypeCompoundMolecular formulaMolecular weightOriginReferences

44InoneWilsonol AC13H24O4244w[42]
45Wilsonol BC13H24O4244w[42]
46Wilsonol CC13H22O4242w[42]
47Wilsonol DC13H24O3228w[42]
48(3S,4S,5S,6S,9S)-Wilsonol EC13H26O3230w[42]
49(3S,4S,5S,6S,9R)-Wilsonol EC13H26O3230w[42]
50Wilsonol FC13H26O3230w[42]
51Wilsonol GC13H24O4244s, w[8, 42]
53Lasianthionoside AC19H32O9404w[42]
55(3S,5R,6S,7E)-Megasfigma-7-ene-3,5,6,9-tetrolC13H24O4244s, w[8, 42]
57Wilsonol HC13H24O5260s, w[8]
58Wilsonol IC13H24O3228w[42]
59Wilsonol JC13H24O3228w[42]
60Wilsonol KC13H22O3226w[42]
61Wilsonol LC13H22O3226w[42]
62(3R,9S)-Megastigman-5-ene-3,9-diol 3-O-β-D-glucopyranosideC19H34O7374w[42]
64Apocynol AC13H20O3224w[42]
65Blumenol AC13H20O3224c, p[43, 44]
67(3S,5R,6S,9S)-3,6,9-Trihydroxymegastigman-7-ene 3-O-β-D-glucopyranosideC19H34O8390c[19]
70Grasshopper ketoneC13H20O3224c[43]
71Asicariside B1C18H30O8374s[8]

72CaryophyllaneCaryophyllene oxideC15H24O220o, s[9, 16]


76CadinaneCinnamoid BC15H24O3252c[48, 49]
77Cinnamoid CC15H24O3252c[48, 49]
79Oxyphyllenodiol AC14H22O3238s[50]
80Oxyphyllenodiol BC14H22O3238s[50]
84δ-CadineneC15H24204c, d, o, z[1013]
85α-MuuroleneC15H24204c, d[14]
86α-CadinolC15H26O222c, d[14]
87α-CalacoreneC15H20200c, o, z[11, 12]

93Cinnamosim BC15H24O4270c[51]
94Cinnamosim AC15H24O3252c[51]
951β,7-Dihydroxyl opposit-4(15)-eneC15H26O2238c[51]
961β,11-Dihydroxyl opposit-4(15)-eneC15H26O2238c[51]


109CurcumeneC15H22202c, o[14]

110GermacraneGermacrene DC15H28208c[47]


114(+)-(6S,7E,9Z)-Abscisic esterC16H22O4278w[42]
116(+)-Abscisic acidC15H20O4264b, s[56, 57]
117Caryolane-1,9β-diolC15H26O2238c[46, 51]
119Cinnamoid AC15H26O2238c[48, 49]
120Cinnamoid DC15H24O2236c[48, 49]
121Cinnamoid EC15H22O2234c[48, 49]
124α-CopaeneC15H24204c, o, z[11, 12]
126Patchouli alcoholC15H26O222c[53]

There are 28 ionone sesquiterpenoids (4471) among these constituents, which are the most abundant sesquiterpene skeletons from the genus Cinnamomum. Although ionone sesquiterpenes are common in natural products, this class of compounds from Cinnamomum has its special features, which are demonstrated as follows: (1) C-4 is connected to a hydroxyl group in some compounds, including 4446, 48, 49, 5153, 57, and 63. (2) The methyl group attached to C-5 is hydroxylated, such as compounds 47, 5861, and 64. (3) The hydroxyl group of C-3 was removed in compound 51. (4) C-2 was connected to a hydroxyl group, such as compounds 51 and 68.

Compounds 72 and 73 belong to caryophyllane sesquiterpenes. Compounds 74 and 75 belong to humulane sesquiterpenes with an eleven-membered ring. Compounds 97100 are guaiane sesquiterpenes, among which 98 was further cyclized on the basis of this structure and has exerted potent antitumor activity.

Cadinane sesquiterpenes include compounds 7688. The methyl groups attached to the C-9 positions of 79 and 80 were degraded, and both of them are derived from C. subavenium. In compounds 81 and 82, which were isolated from C. cassia, the hydrogen at the C-10 position was hydroxylated. In addition, compounds 8388 are common in the volatile oils of Cinnamomum plants.

Eudesmane sesquiterpenes include compounds 8996. Compound 92 is a rearranged sesquiterpene, with its isopropanol group migrating from C-7 to C-6. Furthermore, 9496 are also rearranged sesquiterpenes, with one carbon migrating to form a cyclopentane instead of cyclohexane. Interestingly, the compounds above were all derived from C. cassia.

Compounds 101106 are aromadendrane sesquiterpenes. Furthermore, compounds 107111 are the common components of the volatile oils in Cinnamomum plants. Among these, 107109 are bisabolane sesquiterpenes, while 110 and 111 belong to germacrane and cedrane sesquiterpenes, respectively. Compound 117 is the result of the further cyclization based on the caryophyllane skeleton, and 118 was formed through the migration of one carbon atom based on the structure of 117.

In 2014, Yan et al. separated cinnamonoid A (119) from C. cassia with an unprecedented skeleton, which may be derived from cadinane sesquiterpenes. The possible biosynthesis pathway of 119 was carried out by the cleavage of C-5 and C-6, followed by the construction of C-4 with C-6 and C-5 with C-10. Furthermore, compounds 120122 are rearranged cadinane sesquiterpenes with the cleavage of C-9 and C-4.

Some sesquiterpenoids were reported to show significant anti-inflammatory effects. Tung et al. confirmed that the essential oil of C. osmophloeum twig exhibited a potent inhibition on NO production in LPS-stimulated RAW 264.7 macrophage cells. The anti-inflammatory effects of some constituents from essential oils were also evaluated. Compound 72 (54.0%) exhibited stronger inhibition activities than twig essential oil (48.3%) at the concentration of 10 μg/mL, while 117 exhibited an activity similar to that of twig essential oil, with inhibition rates of 46.1 and 50.9%, respectively [12]. In addition, Guoruoluo et al. evaluated some sesquiterpenoids for the antimicrobial activities. Compounds including 89, 90, 9395, 97, 101, 102, and 117 showed significant antimicrobial activities against Candida albicans with inhibitory zone diameters ranging from 8 to 11 mm. Moreover, 90, 101, and 117 have exhibited moderate inhibitory effects on Escherichia coli and Staphylococcus aureus with inhibitory zone diameters ranging from 7 to 11 mm [51]. In another antibacterial assay, the activities of 79 and 80 against Candida glabrata were also evaluated, and the MIC values were 187.6 and 177.5, respectively [58].

2.3. Diterpenes

A total of 55 diterpenes were isolated from Cinnamomum plants (Table 3 and Figure 3). Most of these were derived from C. cassia (127178), and 179 was derived from C. kotoense and C. philippinense. Nine new diterpene skeletons were found from this species, including ryanodane (cinncassiol B type), 11,12-seco-ryanodane (cinncassiol A type), 7,8-seco-ryanodane (cinncassiol C type), isoryanodane (cinncassiol D type), 10,13-cyclo-12,13-seco-isoryanodane (cinncassiol E type), 12,13-seco-isoryanodane (cinncassiol F type), 11,12-seco-isoryanodane (cinncassiol G type), 6,10-cyclo-12,13-seco-isoryanodane (cinnamomane), and 11,14-cyclo-8,14:12,13-di-seco-isoryanodane (cassiabudane).

No.TypeCompoundMolecular formulaMolecular weightReferences

127Cinncassiol ACinncassiol AC20H30O7382[46, 49]
128Cinncassiol A 19-O-β-D-glucopyranosideC26H40O12544[59, 60]
1311-Acetylcinncassiol AC22H32O8424[59]
133Cinncassiol HC20H30O7382[61]

134Cinncassiol BCinnzeylanolC20H32O7384[61]
136Cinncassiol BC20H32O8400[46]
138Ryanodol 14-monoacetateC22H34O9442[46]

141Cinncassiol CCinncassiol C1C26H38O12542[62]
142Cinncassiol C1-19-O-β-D-glucopyranosideC20H28O7380[63]
143Cinncassiol C2C20H28O6364[63]
144Cinncassiol C3C20H30O7382[63]

145Cinncassiol DCinncassiol D1C26H42O10515[64, 65]
146Cinncassiol D1 glucosideC20H32O5352[64, 65]
1471-Hydroxycinncassiol D1C20H32O6368[45]
148Cinncassiol D2C20H32O6368[64]
149Cinncassiol D2 glucosideC26H42O11531[64]
150Cinncassiol D3C20H32O5352[64]
151Cinncassiol D3-2-O-monoacetateC24H36O8452[46]
152(18S)-3-Dehydroxycinncassiol D3C20H32O5352[45]
153(18S)-3-Dehydroxycinncassiol D3 glucosideC26H42O10515[45]
154(18S)-3,5-Didehydroxy-1,8-dihydroxy-cinncassiol D3C20H32O6368[45]
155(18S)-3-Dehydroxy-8-hydroxy-cinncassiol D3C20H32O6368[45]
156Cinncassiol D4C20H32O5352[66]
157Cinncassiol D4 glucosideC26H42O10515[67]
158Cinncassiol D4-2-O-monoacetateC22H34O6395[46]
15918-HydroxyperseanolC20H32O8400[67, 68]
160PerseanolC20H32O7384[67, 68]
16219-Dehydroxy-13-hydroxy-cinncassiol D1C20H32O6368[45]
163(E)-3-Dehydroxy-13(18)-ene-19-O-β-D-glucopyranosyl-cinncassia D3C26H40O10513[45]

164Cinncassiol ECinncassiol EC20H30O8398[67]

165Cinncassiol FCinncassiol FC20H30O8398[67]

166Cinncassiol GCinncassiol GC20H30O7382[67]
16716-O-β-D-Glucopyranosyl-19-deoxycinncassiol GC26H40O12545[67]
168Cinnamomol CC20H30O6366[45]
169Cinnamomol DC20H30O5350[45]
170Cinnamomol EC20H30O6366[45]
171Cinnamomol FC17H24O4292[45]
17213-O-β-D-Glucopyranosyl-cinnamomol FC23H34O9455[45]

173CinnamomaneCinnamomol AC20H30O8398[68]
174Cinnamomol BC20H30O9414[68]

175CassiabudaneCassiabudanol AC21H32O8412[69]
176Cassiabudanol BC20H30O8398[69]

179PhytolC20H40O297[54, 71]

Among these nine skeletons, the representative compounds of the cinncassiol A-G types were 127, 136, 141, 143145, 148, 150, and 164166. Furthermore, the typical constituents of cinnamomane-type diterpenes were 173 and 174, while those of cassiabudane-type diterpenes were 175 and 176.

The biogenetic relationships of the nine diterpene skeletons were proposed by Zhou et al. (Figure 4) [69]. Cinncassiol B type (134140), that is, renolane-type diterpenes, is a 6/5/5/6/5 pentacyclic skeleton with a ketal structure. The two oxygen atoms connected to C-11 were, respectively, connected to hydrogen and C-6. In addition, cinncassiol A-type diterpenes (127133) have a lactone skeleton produced by the cleavage of the bond between C-11 and C-12, and the formation of the carbon-oxygen double bond at C-11 in cinncassiol B-type diterpenes. The linkage between C-7 and C-8 was cleaved, and two carbonyl groups were formed at the two positions in the cinncassiol B type to produce a diketone skeleton, cinncassiol C type (141144). Cinncassiol D-type diterpenes (145163) are isorinolone diterpenes, which have a pentacyclic ring skeleton produced by the migration of the bond between C-5 and C-6 of cinncassiol B-type diterpenes to the C-1 position. Similarly, cinncassiol G-type diterpenes were formed by the migration of 5,6-bond to C-1 in cinncassiol A-type diterpenes.

The possible biosynthetic pathway of cassiabudane diterpenes was proposed by Zhou et al. [69]. These were formed from 18-hydroxyperseanol (159), an isoryanodane diterpenoid, by the cleavage of the 12,13-bond and migration of the 14,8-bond to C-11 through a series of retro-aldol, aldol, and oxidation reactions.

According to the research conducted by Zeng et al. [67], isoryanodane diterpenoid perseanol (160) is the plausible biosynthetic precursor of cinncassiol F (165) and cinncassiol G (166), and biosynthetic pathways have been proposed. These were, respectively, formed by the cleavage of the 12,13-bond and 11,12-bond from 160 through a series of reactions under the catalysis of acid. In addition, Zhou et al. [68] proposed that cinnamomane diterpenoids are also generated from perseanol (160) through a series of retro-aldol, aldol, and oxidation reactions.

Some diterpenes of Cinnamomum have been reported to demonstrate immunomodulatory potency, covering immunostimulative and immunosuppressive activities.

Zhou et al. reported that the cassiabudane diterpenes 175 and 176 showed strong immunostimulative activity. Both of these significantly promoted the expansion of ConA-induced murine T cells with enhancement rates of 10.38 and 19.96%, respectively, at a dose of 0.3906 μM and enhanced the proliferation of LPS-induced murine B cells with enhancement rates of 52.13 and 55.06%, respectively, at the same dose [69]. In another assay conducted by Zhou et al., cinnamomane diterpenes 173 and 174 could promote the proliferation of ConA-induced murine T cells with enhancement rates of 59 and 64%, respectively, at the concentration of 0.3906 μM [68]. By comparing the results, we found that cinnamomane diterpenes exhibited stronger immunostimulative effects than cassiabudane diterpenes, showing that the 6,10-cyclo-12,13-seco-isoryanodane skeleton could probably promote the activity. In addition, a hydroxyl group connected to C-2 in cinnamomane diterpenes could enhance their immunostimulative activity and C-13 connecting to a hydroxyl group in cassiabudane diterpenes exerted stronger effect compared with connecting to a methoxy group.

In the ConA/LPS-induced splenocyte proliferation assay conducted by Zeng et al., cinncassiol G (166) inhibited 94.5% of ConA-induced murine T-cell proliferation at a dose of 100 μM, showing strong immunosuppressive activity. More importantly, 166 and 177 exhibited significant inhibitory effects on T-cell proliferation even at 50 μM, with inhibition rates of 86.1% and 58.8%, respectively. It was also concluded that the 11,6-lactone moiety plays an important role in immunosuppressive activity, which accounts for the stronger inhibition of 166 compared to that of 177 [67]. According to the research by Zhou et al., some diterpenes, including 145, 152, 154, 168170, 173, and 174, could significantly promote ConA-induced murine T-cell proliferation, with proliferation rates of up to 78% at five different concentrations (0.391 to 100 μM). When the concentration was lower than 25 μM, compounds 168 and 169 appeared to promote proliferation. However, these appeared to inhibit the growth at the concentration of 100 μM [45].

In addition, some diterpenes have been reported to exert anti-inflammatory activities. He et al. reported that compounds 127, 129, 130, 133, 134, and 135 had a good performance of inhibiting NO production, with IC50 values ranging from 72.3 to 81.8 μM [61].

2.4. Triterpenes

Two triterpenes were obtained from the Cinnamomum genus, including squalene (180) from C. kotoense, C. philippinense, and C. subavenium, and oleanolic acid (181) from C. camphora (Table 4 and Figure 5).

No.CompoundMolecular formulaMolecular weightOriginReferences

180SqualeneC30H50410k, q, s[54, 71]
181Oleanolic acidC30H48O3456d[62]

3. Conclusion

The medicinal value of the genus Cinnamomum has attracted much attention around the world, and many studies have been conducted. Most importantly, terpenes are the most abundant in the genus Cinnamomum, with various novel skeletons and significant biological activities, including immunomodulatory, anti-inflammatory, antimicrobial, antioxidant, and anticancer activities. In the present review, the research progress on chemical structures and biological effects of terpenes from Cinnamomum has been summarized. This can not only increase the understanding of the genus Cinnamomum, but also promote the better use of plants and further development of new drugs. Nevertheless, research on Cinnamomum remains incomplete, and more investigations are needed in the future.

First, chemical research on Cinnamomum plants has focused on only a few species like C. cassia and C. subavenium. Some other plants have gradually become research hotspots, but are only limited to the study of volatile oils. Cinnamomum plants have great economic and medicinal value and need to be further explored in future studies. Second, the diterpenes from Cinnamomum have shown significant immunomodulatory activities according to the findings. However, this only stays in the stage of cell activity in vitro. Thus, further pharmaceutical and in vivo activity experiments can be performed to promote the development of new drugs.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

M.T.W. conceptualized the review and drafted the initial version of the manuscript. L.N. and H.X.L. undertook the database search for the literature. H.Y.X., S.Q.Z., and X.X.Z. significantly contributed to the gathering of information and discussions of the manuscript. All authors read and approved the final manuscript.


This work was supported by the National Natural Science Foundation of China (no. 31700292) and Special Funds for Science and Technology Commissioners of Fujian Province (103/KTP19108A and 103/K1517070A).


  1. A. Asadollahi, M. Khoobdel, A. Z. Ramazani, S. Azarmi, and S. H. Mosawi, “Effectiveness of plant-based repellents against different Anopheles species: a systematic review,” Malaria Journal, vol. 18, no. 1, p. 436, 2019. View at: Publisher Site | Google Scholar
  2. S. Kumar, R. Kumari, and S. Mishra, “Pharmacological properties and their medicinal uses of Cinnamomum: a review,” Journal of Pharmacy and Pharmacology, vol. 71, no. 12, pp. 1735–1761, 2019. View at: Publisher Site | Google Scholar
  3. J. Zeng, Y. Xue, Y. Lai et al., “A new phenolic glycoside from the barks of Cinnamomum cassia,” Molecules, vol. 19, no. 11, pp. 17727–17734, 2014. View at: Publisher Site | Google Scholar
  4. J. Zhao and J. S. Ma, “Phytochemicals and biological activities of the genus Cinnamomum,” Journal of Pharmacognosy and Phytochemistry, vol. 4, no. 1, pp. 27–34, 2016. View at: Google Scholar
  5. S. Wuu-Kuang, “Taxonomic revision of Cinnamomum (Lauraceae) in borneo,” Blumea-Biodiversity, Evolution and Biogeography of Plants, vol. 56, no. 3, pp. 241–264, 2011. View at: Publisher Site | Google Scholar
  6. R. Singh and T. Jawaid, “Cinnamomum camphora (kapur): review,” Pharmacognosy Journal, vol. 4, no. 28, pp. 1–5, 2012. View at: Publisher Site | Google Scholar
  7. D. F. Huang, J.-G. Xu, J.-X. Liu, H. Zhang, and Q. P. Hu, “Chemical constituents, antibacterial activity and mechanism of action of the essential oil from Cinnamomum cassia bark against four food-related bacteria,” Microbiology, vol. 83, no. 4, pp. 357–365, 2014. View at: Publisher Site | Google Scholar
  8. X. Hao, J. Chen, Y. Lai et al., “Chemical constituents from leaves of Cinnamomum subavenium,” Biochemical Systematics and Ecology, vol. 61, pp. 156–160, 2015. View at: Publisher Site | Google Scholar
  9. G. C. Huang, C. L. Kao, H. C. Yeh, W. J. Li, H. T. Li, and C. Y. Chen, “A new diphenyl ether from Cinnamomum subavenium,” Chemistry of Natural Compounds, vol. 54, no. 5, pp. 869–871, 2018. View at: Publisher Site | Google Scholar
  10. A. M. Taha and O. A. Eldahshan, “Chemical characteristics, antimicrobial, and cytotoxic activities of the essential oil of Egyptian Cinnamomum glanduliferum bark,” Chemistry and Biodiversity, vol. 14, no. 5, 2017. View at: Publisher Site | Google Scholar
  11. M. Saleem, H. N. Bhatti, M. I. Jilani, and M. A. Hanif, “Bioanalytical evaluation of Cinnamomum zeylanicum essential oil,” Natural Product Research, vol. 29, no. 19, pp. 1857–1859, 2015. View at: Publisher Site | Google Scholar
  12. Y.-T. Tung, M.-T. Chua, S.-Y. Wang, and S.-T. Chang, “Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs,” Bioresource Technology, vol. 99, no. 9, pp. 3908–3913, 2008. View at: Publisher Site | Google Scholar
  13. H. Jiang, J. Wang, L. Song et al., “GC×GC-TOFMS analysis of essential oils composition from leaves, twigs and seeds of Cinnamomum camphora L. Presl and their insecticidal and repellent activities,” Molecules, vol. 21, no. 4, p. 423, 2016. View at: Publisher Site | Google Scholar
  14. Z. Rao, F. Xu, T. Wen, F. Wang, W. Sang, and N. Zeng, “Protective effects of essential oils from Rimulus cinnamon on endotoxin poisoning mice,” Biomedicine & Pharmacotherapy, vol. 101, pp. 304–310, 2018. View at: Publisher Site | Google Scholar
  15. S.-G. Liao, T. Yuan, C. Zhang, S.-P. Yang, Y. Wu, and J.-M. Yue, “Cinnacassides A-E, five geranylphenylacetate glycosides from Cinnamomum cassia,” Tetrahedron, vol. 65, no. 4, pp. 883–887, 2009. View at: Publisher Site | Google Scholar
  16. X. Liu, J. Fu, X.-J. Yao et al., “Phenolic constituents isolated from the twigs of Cinnamomum cassia and their potential neuroprotective effects,” Journal of Natural Products, vol. 81, no. 6, pp. 1333–1342, 2018. View at: Publisher Site | Google Scholar
  17. J.-F. Zeng, H.-C. Zhu, J.-W. Lu, L.-Z. Hu, J.-C. Song, and Y.-H. Zhang, “Two new geranylphenylacetate glycosides from the barks of Cinnamomum cassia,” Natural Product Research, vol. 31, no. 15, pp. 1812–1818, 2017. View at: Publisher Site | Google Scholar
  18. H. Fuchino, A. Yazawa, F. Kiuchi, N. Kawahara, Y. Takahashi, and M. Satake, “Novel monoterpene lactones from Cinnamomum inunctum,” Chemical and Pharmaceutical Bulletin, vol. 63, no. 10, pp. 833–836, 2015. View at: Publisher Site | Google Scholar
  19. Y. Guoruoluo, H. Zhou, W. Wang, J. Zhou, H. A. Aisa, and G. Yao, “Chemical constituents from the immature buds of Cinnamomum cassia (Lauraceae),” Biochemical Systematics and Ecology, vol. 78, pp. 102–105, 2018. View at: Publisher Site | Google Scholar
  20. Y.-Q. Li, D.-X. Kong, and H. Wu, “Analysis and evaluation of essential oil components of cinnamon barks using GC-MS and FTIR spectroscopy,” Industrial Crops and Products, vol. 41, pp. 269–278, 2013. View at: Publisher Site | Google Scholar
  21. Y.-R. Li, C.-S. Fu, W.-J. Yang et al., “Investigation of constituents from Cinnamomum camphora (L.) J. Presl and evaluation of their anti-inflammatory properties in lipopolysaccharide-stimulated RAW 264.7 macrophages,” Journal of Ethnopharmacology, vol. 221, pp. 37–47, 2018. View at: Publisher Site | Google Scholar
  22. M.-J. Cheng, W.-L. Lo, W.-S. Tseng, H.-C. Yeh, and C.-Y. Chen, “A novel normonoterpenoid from the stems of Cinnamomum reticulatum Hay,” Natural Product Research, vol. 24, no. 8, pp. 732–736, 2010. View at: Publisher Site | Google Scholar
  23. R.-J. Lin, W.-L. Lo, Y.-D. Wang, and C.-Y. Chen, “A novel cytotoxic monoterpenoid from the leaves of Cinnamomum subavenium,” Natural Product Research, vol. 22, no. 12, pp. 1055–1059, 2008. View at: Publisher Site | Google Scholar
  24. C.-H. Lee, C.-N. Kuo, H.-L. Chen, and C.-Y. Chen, “Review on pharmacological activities of Cinnamomum subavenium,” Natural Product Research, vol. 27, no. 11, pp. 988–991, 2013. View at: Publisher Site | Google Scholar
  25. Z. E. Suntres, J. Coccimiglio, and M. Alipour, “The bioactivity and toxicological actions of carvacrol,” Critical Reviews in Food Science and Nutrition, vol. 55, no. 3, pp. 304–318, 2015. View at: Publisher Site | Google Scholar
  26. I. A. Bnyan, A. T. Abid, and H. N. Obied, “Antibacterial activity of carvacrol against different types of bacteria,” Journal of Natural Science Research, vol. 4, no. 9, pp. 13–16, 2014. View at: Google Scholar
  27. M. Sharifi-Rad, E. M. Varoni, M. Iriti et al., “Carvacrol and human health: a comprehensive review,” Phytotherapy Research, vol. 32, no. 9, pp. 1675–1687, 2018. View at: Publisher Site | Google Scholar
  28. A. Marchese, C. R. Arciola, R. Barbieri et al., “Update on monoterpenes as antimicrobial agents: a particular focus on p-cymene,” Materials (Basel), vol. 10, no. 8, 2017. View at: Publisher Site | Google Scholar
  29. S.-S. Cheng, C.-G. Huang, Y.-J. Chen, J.-J. Yu, W.-J. Chen, and S.-T. Chang, “Chemical compositions and larvicidal activities of leaf essential oils from two eucalyptus species,” Bioresource Technology, vol. 100, no. 1, pp. 452–456, 2009. View at: Publisher Site | Google Scholar
  30. E. Evergetis, A. Michaelakis, and S. A. Haroutounian, “Exploitation of Apiaceae family essential oils as potent biopesticides and rich source of phellandrenes,” Industrial Crops and Products, vol. 41, pp. 365–370, 2013. View at: Publisher Site | Google Scholar
  31. A. S. Raeini, Z. Hafizibarjin, M. E. Rezvani, F. Safari, F. A. Aghda, and F. Z. Mehrjerdi, “Carvacrol suppresses learning and memory dysfunction and hippocampal damages caused by chronic cerebral hypoperfusion,” Naunyn-Schmiedebergs Archives of Pharmacology, vol. 393, no. 4, pp. 581–589, 2020. View at: Publisher Site | Google Scholar
  32. Z. Hakimi, H. Salmani, N. Marefati et al., “Protective effects of carvacrol on brain tissue inflammation and oxidative stress as well as learning and memory in lipopolysaccharide-challenged rats,” Neurotoxicity Research, vol. 37, no. 4, pp. 965–976, 2020. View at: Publisher Site | Google Scholar
  33. T. M. de Oliveira, R. B. F. de Carvalho, I. H. F. da Costa et al., “Evaluation of p-cymene, a natural antioxidant,” Pharmaceutical Biology, vol. 53, no. 3, pp. 423–428, 2015. View at: Publisher Site | Google Scholar
  34. M. Hotta, R. Nakata, M. Katsukawa, K. Hori, S. Takahashi, and H. Inoue, “Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expression,” Journal of Lipid Research, vol. 51, no. 1, pp. 132–139, 2010. View at: Publisher Site | Google Scholar
  35. W.-C. Lee, H. A. Jung, J. S. Choi, Y. S. Kim, and S.-M. Lee, “Protective effects of luteolin against apoptotic liver damage induced byd-galactosamine/lipopolysaccharide in mice,” Journal of Natural Products, vol. 74, no. 9, pp. 1916–1921, 2011. View at: Publisher Site | Google Scholar
  36. J. Li, X. Zhang, and H. Huang, “Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice,” International Immunopharmacology, vol. 23, no. 2, pp. 523–529, 2014. View at: Publisher Site | Google Scholar
  37. J. Ma, H. Xu, J. Wu, C. Qu, F. Sun, and S. Xu, “Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation,” International Immunopharmacology, vol. 29, no. 2, pp. 708–713, 2015. View at: Publisher Site | Google Scholar
  38. X. B. Sun, S. M. Wang, T. Li, and Y. Q. Yang, “Anticancer activity of linalool terpenoid: apoptosis induction and cell cycle arrest in prostate cancer cells,” Tropical Journal of Pharmaceutical Research, vol. 14, no. 4, 2015. View at: Publisher Site | Google Scholar
  39. N. Okumura, H. Yoshida, Y. Nishimura, Y. Kitagishi, and S. Matsuda, “Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells,” Oncology Letters, vol. 3, no. 2, pp. 321–324, 2012. View at: Publisher Site | Google Scholar
  40. M. G. de Oliveira, R. B. Marques, M. F. de Santana et al., “Alpha-terpineol reduces mechanical hypernociception and inflammatory response,” Basic and Clinical Pharmacology and Toxicology, vol. 111, no. 2, pp. 120–125, 2012. View at: Publisher Site | Google Scholar
  41. A. T. Rufino, M. Ribeiro, F. Judas et al., “Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity,” Journal of Natural Products, vol. 77, no. 2, pp. 264–269, 2014. View at: Publisher Site | Google Scholar
  42. P. Shu, X. Wei, Y. Xue et al., “Wilsonols A-L, megastigmane sesquiterpenoids from the leaves of Cinnamomum wilsonii,” Journal of Natural Products, vol. 76, no. 7, pp. 1303–1312, 2013. View at: Publisher Site | Google Scholar
  43. X. Liu, J. Yang, J. Fu et al., “Phytochemical and chemotaxonomic studies on the twigs of Cinnamomum cassia (Lauraceae),” Biochemical Systematics and Ecology, vol. 81, pp. 45–48, 2018. View at: Publisher Site | Google Scholar
  44. A. Pardede, M. Adfa, A. Juliari Kusnanda, M. Ninomiya, and M. Koketsu, “Flavonoid rutinosides from Cinnamomum parthenoxylon leaves and their hepatoprotective and antioxidant activity,” Medicinal Chemistry Research, vol. 26, no. 9, pp. 2074–2079, 2017. View at: Publisher Site | Google Scholar
  45. L. Zhou, “Studies on the Chemical Constituents and Immunomodulatory Activities of the Leaves of Cinnamomum Cassia”, Huazhong University of Science and Technology, Wuhan, China, 2016.
  46. Q. L. Hu, “The Discovery of Components and Research on Bioactivities of Cinnamomum Cassia and Carpesium Abrotanoides”, Lanzhou University, Lanzhou, China, 2018.
  47. C.-T. Chang, W.-L. Chang, J.-C. Hsu, Y. Shih, and S.-T. Chou, “Chemical composition and tyrosinase inhibitory activity of Cinnamomum cassia essential oil,” Botanical Studies, vol. 54, no. 1, p. 10, 2013. View at: Publisher Site | Google Scholar
  48. Y.-M. Yan, P. Fang, M.-T. Yang, N. Li, Q. Lu, and Y.-X. Cheng, “Anti-diabetic nephropathy compounds from Cinnamomum cassia,” Journal of Ethnopharmacology, vol. 165, pp. 141–147, 2015. View at: Publisher Site | Google Scholar
  49. C. Zhang, L. Fan, S. Fan et al., “Cinnamomum cassia presl: a review of its traditional uses, phytochemistry, pharmacology and toxicology,” Molecules, vol. 24, no. 19, 2019. View at: Publisher Site | Google Scholar
  50. C.-Y. Chen and Y.-D. Wang, “Norcadinane sesquiterpene from the roots of Cinnamomum subavenium,” Chemistry of Natural Compounds, vol. 47, no. 3, pp. 461-462, 2011. View at: Publisher Site | Google Scholar
  51. Y. Guoruoluo, H. Zhou, J. Zhou, H. Zhao, H. A. Aisa, and G. Yao, “Isolation and characterization of sesquiterpenoids from Cassia buds and their antimicrobial activities,” Journal of Agricultural and Food Chemistry, vol. 65, no. 28, pp. 5614–5619, 2017. View at: Publisher Site | Google Scholar
  52. R.-J. Lin, M.-J. Cheng, J.-C. Huang et al., “Cytotoxic compounds from the stems of Cinnamomum tenuifolium,” Journal of Natural Products, vol. 72, no. 10, pp. 1816–1824, 2009. View at: Publisher Site | Google Scholar
  53. Y. K. Xiong, X. L. Liu, Z. J. Mu et al., “Differences of chemical constituents of volatile oil from Cinnamomum before and after drying and comparison of anti-drug resistant bacteria activities,” Research and Exploration in Laboratory, vol. 37, pp. 56–59, 2018. View at: Google Scholar
  54. C. Y. Chen, Y. D. Wang, and C. J. Wang, “Chemical constituents from the leaves of Cinnamomum philippinense,” Chemistry of Natural Compounds, vol. 46, no. 6, pp. 941-942, 2011. View at: Publisher Site | Google Scholar
  55. H.-C. Lin and S.-S. Lee, “Dibenzocycloheptanoids from the leaves of Cinnamomum subavenium,” Journal of Natural Products, vol. 75, no. 10, pp. 1735–1743, 2012. View at: Publisher Site | Google Scholar
  56. S. Subehan, S. Kadota, and Y. Tezuka, “In VitroMechanism-based inactivation of cytochrome P450 3A4 by a new constituent of Cinnamomum burmani,” Planta Medica, vol. 74, no. 12, pp. 1474–1480, 2008. View at: Publisher Site | Google Scholar
  57. C. Y. Chen and Y. D. Wang, “A novel sequiterpenoid from the leaves of Cinnamomum subavenium,” Chemistry of Natural Compounds, vol. 47, no. 2, pp. 215–217, 2011. View at: Publisher Site | Google Scholar
  58. L. Hua-Yong, Z. Yu, M. Xiao-Pan, and J. Sai, “Novel sesquiterpenoids isolated from Chimonanthus praecox and their antibacterial activities,” Chinese Journal of Natural Medicines, vol. 16, no. 8, pp. 621–627, 2018. View at: Publisher Site | Google Scholar
  59. V. C. Pham, T. T. A. Nguyen, T. O. Vu, T. Q. Cao, B. S. Min, and J. A. Kim, “Five new diterpenoids from the barks of Cinnamomum cassia (L.) J. Presl,” Phytochemistry Letters, vol. 32, pp. 23–28, 2019. View at: Publisher Site | Google Scholar
  60. A. Yagi, N. Tokubuchi, T. Nohara, G. Nonaka, I. Nishioka, and A. Koda, “The constituents of cinnamomi cortex. I. Structures of cinncassiol A and its glucoside,” Chemical & Pharmaceutical Bulletin, vol. 28, no. 5, pp. 1432–1436, 1980. View at: Publisher Site | Google Scholar
  61. S. He, Y. Jiang, and P.-F. Tu, “Three new compounds from Cinnamomum cassia,” Journal of Asian Natural Products Research, vol. 18, no. 2, pp. 134–140, 2016. View at: Publisher Site | Google Scholar
  62. T. Nohaka, I. Nishioka, N. Tokubuchi, K. Miyahara, and T. Kawasaki, “Cinncassiol C1, a novel type of diterpene from cinnamomi cortex,” Chemical and Pharmaceutical Bulletin, vol. 28, no. 6, pp. 1969-1970, 1980. View at: Publisher Site | Google Scholar
  63. Y. Kashiwada, T. Nohara, T. Tomimatsu, and I. Nishioka, “Constituents of cinnamomi cortex. IV. Structures of cinncassiols C1 glucoside, C2 and C3,” Chemical and Pharmaceutical Bulletin, vol. 29, no. 9, 1981. View at: Publisher Site | Google Scholar
  64. T. Nohara, Y. Kashiwada, K. Murakami et al., “Constituents of cinnamomi cortex. V. Structures of five novel diterpenes, cinncassiols D1, D1 glucoside, D2,D2 glucoside and D3,” Chemical & Pharmaceutical Bulletin, vol. 29, no. 9, pp. 2451–2459, 1981. View at: Publisher Site | Google Scholar
  65. T. Nohara, Y. Kashiwada, T. Tomimatsu, M. Kido, N. Tokubuchi, and I. Nishioka, “Cinncassiol D1 and its glucoside, novel pentacyclic diterpenes from cinnamomi cortex,” Tetrahedron Letters, vol. 21, no. 27, pp. 2647-2648, 1980. View at: Publisher Site | Google Scholar
  66. T. Nohara, Y. Kashiwada, T. Tomimatsu, and I. Nishioka, “Two novel diterpenes from bark of Cinnamomum cassia,” Phytochemistry, vol. 21, no. 8, pp. 2130–2132, 1982. View at: Publisher Site | Google Scholar
  67. J. Zeng, Y. Xue, P. Shu et al., “Diterpenoids with immunosuppressive activities from Cinnamomum cassia,” Journal of Natural Products, vol. 77, no. 8, pp. 1948–1954, 2014. View at: Publisher Site | Google Scholar
  68. L. Zhou, Y. Tuo, Y. Hao et al., “Cinnamomols A and B, immunostimulative diterpenoids with a new carbon skeleton from the leaves of Cinnamomum cassia,” Organic Letters, vol. 19, no. 11, pp. 3029–3032, 2017. View at: Publisher Site | Google Scholar
  69. H. Zhou, Y. Guoruoluo, Y. Tuo et al., “Cassiabudanols A and B, immunostimulative diterpenoids with a Cassiabudane carbon skeleton featuring a 3-oxatetracyclo [,6.010,14] pentadecane scaffold from Cassia buds,” Organic Letters, vol. 21, no. 2, pp. 549–553, 2019. View at: Publisher Site | Google Scholar
  70. T. M. Ngoc, D. T. Ha, I.-S. Lee et al., “Two new diterpenes from the twigs of Cinnamomum cassia,” Helvetica Chimica Acta, vol. 92, no. 10, pp. 2058–2062, 2009. View at: Publisher Site | Google Scholar
  71. F.-C. Chen, C.-F. Peng, I.-L. Tsai, and I.-S. Chen, “Antitubercular constituents from the stem wood of Cinnamomum kotoense,” Journal of Natural Products, vol. 68, no. 9, pp. 1318–1323, 2005. View at: Publisher Site | Google Scholar

Copyright © 2020 Meiting Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.